baber/WOPTO huggingface dataset:
Patent AU-2005246996-B2 (AU)
Title: Joint prosthesis with infinitely positionable head
Inventor: KLOTZ CONRAD L
IPC: A61F2/30
Filed: 2005-12-21
Granted: 2011-03-31
Abstract: A joint prosthesis includes a bone engaging portion, such as a stem, and articulating component, such as a humeral head, and an insert component that supports the articulating component and is removable from the stem. A mating component mates with the humeral head and is configured to engage the insert component at adjustable angles according to the anatomy of the patient's joint. In a revision surgery, the stem remains within the patient's bone while the insert component is removed with the mating component and humeral head fixed to the insert component. A new insert component may be prepared with the mating component and humeral head oriented to replicate the angular orientation of the previous prosthesis. The new insert component is then mounted within an insert cavity in the implanted stem and rigidly fastened to complete the revision.
Patent AU-2005253897-B2 (AU)
Title: Treatment of non alcoholic steatotic hepatitis (NASH)
Inventor: VAN DEVENTER SANDER JAN HENDRIK
IPC: A61K48/00
Filed: 2005-06-20
Granted: 2011-09-01
Abstract: The present invention relates to a method for treating nonalcoholic steatotic hepatitis (NASH) in a subject by administering an effective amount of a lipoprotein lipase (LPL) therapeutic to the subject. The LPL therapeutic is advantageoulsy a S447X protein or a derivative or variant thereof, or a nucleic acid encoding such a protein. The LPL therapeutic may be used in a gene therapy vector.
Patent AU-2005261721-B2 (AU)
Title: p75NTR screening assay for indentifying modulators of apoptosis
Inventor: BRUINZEEL WOUTER DAVID
IPC: C12N15/88
Filed: 2005-07-11
Granted: 2011-02-24
Abstract: The present invention provides a method to identify a test compounds capability to modulate p75.sup.NTR induced apoptosis, said method comprising: i. Transfecting a suspension of eukaryotic cells with a vector encoding SEQ ID No.4 OR SEQ ID No.6), ii. Contacting said cells with the compound to be tested, and iii. Determine the apoptotic response in said cells, wherein an alteration in apoptotic response in the presence of said test compound compared to the apoptotic response in the absence of the test compound is an indication of the ability of the test compound to modulate p75.sup.NTR induced apoptosis.
Patent AU-2005283833-B2 (AU)
Title: Microseismic event detection and location by continuous map migration
Inventor: JULIAN DREW
IPC: G01V1/00
Filed: 2005-09-09
Granted: 2011-09-15
Abstract: The present invention provides methods and systems for microseismic hydraulic fracture monitoring in real-time. The methods and systems of the present invention may include continuous map migration of recorded microseismic signals. The methods and systems provide robust automated simultaneous detection and location of microseismic events.
Patent AU-2005293340-B2 (AU)
Title: Fastening band
Inventor: DANIEL WARD
IPC: F16L3/233
Filed: 2005-10-10
Granted: 2011-06-30
Abstract: A fastener for holding or clamping at least one object is provided that comprises: a band (10) formed into a closed loop, said band having a first end and a second end and teeth (18) on its outer surface; and a head (12) that holds the band in a closed loop and comprises a first and a second passageway (20, 22). The second end of the band is secured in a second passageway (20) by teeth (24) that engage with the teeth of the band. The band is then passed around the object to form a loop and the first end of the band is pushed into the first passageway (22) that also includes teeth that engages the teeth on the band and prevents the band from being pulled out of the first passageway. A chamber (34) is located at one end of the first passageway (22) and has an opening in the outer face of the head. The chamber is accessible from outside the head through the opening to enable a leading part of the first end of the band that has passed through the passageway to be engaged in the chamber and pulled to tighten the band. The leading part of the first end is accommodated within said chamber, to provide a compact low-profile clamp with no sharp edges that could cause snagging.
Patent AU-2005309870-B2 (AU)
Title: Coating composition and methods
Inventor: KILLILEA T HOWARD
IPC: C09D175/04
Filed: 2005-11-17
Granted: 2011-03-03
Abstract: The present invention provides coating compositions that include substantially non-irritating ethylenically unsaturated compounds and have one or more of the following properties: high performance, low VOC levels, substantially no formaldehyde content, and low irritation levels.
Patent AU-2006259326-B2 (AU)
Title: Catalyst for hydrogen production from water gas shift reaction
Inventor: SITICHAI NATESAKHAWAT
IPC: C08F4/60
Filed: 2006-06-15
Granted: 2011-06-23
Abstract: Fe-Al-Cu catalysts have numerous industrial applications, for example, as catalysts in a water gas shift reactor. A method of producing a Fe-Al-Cu catalyst comprises the steps of providing an organic iron precursor, dissolving the organic iron precursor in a solvent solution, adding an aqueous solution comprising aluminum nitrate and copper nitrate to the organic iron precursor-solvent solution, precipitating a gel comprising Fe-Al-Cu by adding a base, and drying the gel to form the Fe-Al-Cu catalyst.
Patent AU-2006262711-B2 (AU)
Title: Compositions and methods for immunomodulation in an organism
Inventor: LEFRANCOIS LEO
IPC: C12P21/04
Filed: 2006-05-17
Granted: 2013-01-31
Abstract: The present invention relates to a therapeutic polypeptide and methods for its creation and use for modulating an immune response in a host organism in need thereof. In particular, the invention relates to the administration to an organism in need thereof, of an effective amount of a pre-coupled polypeptide complex comprising a lymphokine polypeptide portion, for example IL- 15 (SEQ ID NO: 5, 6), IL-2 (SEQ ID NO: 10, 12)or combinations of both, and an interleukin receptor polypeptide portion, for example IL- 15Ra (SEQ ID NO: 7, 8), IL-2Ra (SEQ ID NO: 9, 11) or combinations of both, for augmenting the immune system in, for example, cancer, SCID, AIDS, or vaccination; or inhibiting the immune system in, for example, rheumatoid arthritis, or Lupus. The therapeutic complex of the invention surprisingly demonstrates increased half-life, and efficacy
Patent AU-2006349461-B2 (AU)
Title: Improved reciprocating devices
Inventor: HINDERKS MITJA VICTOR
IPC: F02F3/00
Filed: 2006-10-05
Granted: 2014-04-03
Abstract: The disclosure relates to fluid working devices including reciprocating internal combustion engines, compressors and pumps. A number of arrangements for pistons and cylinders of unconventional configuration are described, mostly intended for use in reciprocating internal combustion IC engines operating without cooling. Included are toroidal combustion or working chambers, some with fluid flow through the core of the toroid, pistons reciprocating between pairs of working chambers, tensile valve actuation, tensile links between piston and crankshaft, energy absorbing piston - crank links, crankshafts supported on gas bearings, cylinders rotating in housings, injectors having components reciprocate or rotate during fuel delivery. In some embodiments pistons may rotate while reciprocating. High temperature exhaust emissions systems are described, including those containing filamentary material, as are procedures for reducing emissions during cold start by means of valves at reaction volume exit. Compound engines having the new engines as a reciprocating stage are described. Improved vehicles, aircraft, marine craft and transmissions adapted to receive or be linked to the improved IV engines are also disclosed.
Patent AU-2007200844-B2 (AU)
Title: Needle holder
Inventor: BUCHTER MARK S
IPC: B21G1/12
Filed: 2007-02-27
Granted: 2012-07-19
Abstract: NEEDLE HOLDER Abstract A needle holder (10) that includes a fixed support member (22) having an aperture (42) therethrough, and a movable holding member (12) mounted to the fixed s member. The movable holding member contains a slot for receiving a needle and is movable between a first needle blank receiving position which enables receipt of said needle blank within said slot and a second needle blank holding position wherein the needle blank is held against the fixed support member (22). C\". C"j C\\1 CM, C\j CL&. 50-
Patent AU-2007201799-B2 (AU)
Title: Traction drive for elevator
Inventor: YOSHITARO OGAVA MARIO
IPC: H02K1/27
Filed: 2007-04-23
Granted: 2011-07-21
Abstract: Abstract A traction drive for an elevator comprises a sheave 5 for actuating a transmission means of the elevator and a synchronous motor, said synchronous motor comprising a stator I with 5 at least one winding for generating a magnetic field rotating around a motor axis and a rotor 3 comprising at least one permanent magnet 7, said rotor being coupled to said sheave for transmitting a torque. According to the present invention said permanent magnet 7 is longer in the motor axis direction than the stator core and/or said rotor is composed from a plurality of separate permanent magnets 7 and separate magnetic sectors 10 6 provided alternating in a circumferential direction perpendicular to the motor axis to concentrate the magnetic flux in axial and/or radial direction. Fig. I I" :1 7-- I' SW StT~1U: ~tJ .1? FgI, L 'I -F *~ ii/ 'II I, Ii </2 N
Patent AU-2007204184-B2 (AU)
Title: Telephone communication method and system
Inventor: RUCHKO MAKSYM
IPC: H04M3/487
Filed: 2007-01-16
Granted: 2012-03-15
Abstract: The invention concerns telecommunications methods and systems, and more particularly methods and systems for enabling respondents, who may be potential customers, to respond to advertisements for items (goods or services) advertised by or on behalf of advertisers. Telecommunications methods and systems of the invention provide selective communication routing or forwarding to advertisers of communications made to anonymous contact identifiers selected from a pool of anonymous contact identifiers, each anonymous contact identifier able to be allocated to an item to be advertised by or on behalf of the advertiser. The anonymous contact identifier is a public telephone number or an email address, for example. The service is provided by way of hosted system for use by a plurality of advertisers. The invention has particular application in the area of classified or personal advertising in printed or online publications, such as for real estate, automotive, travel or job advertising, for sale or auction item advertising, or for dating agency advertising.
Patent AU-2007238829-B2 (AU)
Title: Incubation condition monitoring device
Inventor: HUBERTS JOHN
IPC: C12M1/34
Filed: 2007-04-11
Granted: 2012-06-14
Abstract: An incubation condition monitoring device has at least one reader unit (10) to measure selected characteristics with an incubator (2). The reader unit transmits the information to a receiver/transmitter (12) within the incubator to receive the measurements and to transmit the measurements of the selected characteristics to a data logger (14) outside the incubator. A monitor and display system (16) monitors and displays the measurements of the selected characteristics. The selected characteristics within the incubator can be temperature and pH.
Patent AU-2007260207-B2 (AU)
Title: Pharmaceutical composition with synergistic anticonvulsant effect
Inventor: STOHR THOMAS
IPC: A61K31/195
Filed: 2007-06-15
Granted: 2012-11-08
Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
Patent AU-2007334598-B2 (AU)
Title: Non-nucleoside reverse transcriptase inhibitors
Inventor: SU DAI-SHI
IPC: A61K31/4192
Filed: 2007-12-06
Granted: 2013-01-17
Abstract: Compounds of Formula I are HIV reverse transcriptase inhibitors, wherein V, W, X, Y, Z, R
Patent AU-2007336751-B2 (AU)
Title: New fusion molecule based on novel TAA variant
Inventor: BELLDEGRUN ARIE S
IPC: A61K38/00
Filed: 2007-12-21
Granted: 2013-08-01
Abstract: This invention provides novel carbonic anhydrase (CAIX) nucleic acid and peptide sequences, as well as related methods and compositions, including anti-cancer immunogenic agent(s) (e.g. vaccines and chimeric molecules) that elicit an immune response specifically directed against cancer cells expressing a CAIX antigenic marker. The novel CAIX variant and related compositions are useful in a wide variety of treatment modalities including, but not limited to protein vaccination, DNA vaccination, and adoptive immunotherapy.
Patent AU-2007359657-B2 (AU)
Title: Medical apparatus
Inventor: RICCARDO PELLEGRINI
IPC: A61M1/16
Filed: 2007-10-03
Granted: 2011-06-30
Abstract: In a hemodiafiltration apparatus, a membrane device (2) comprises a blood chamber (3) and a fluid chamber (4) separated by a semipermeable membrane (5). A grounding device (17) is connected to the discharge line by means of a tubular connector (16) made of an electrically-conductive plastic material. The grounding device can disconnect the grounding connection if the leakage current measured on a patient ( 1 ) connected to the apparatus exceeds a predetermined value. The apparatus can be classified as Cardiac Floating and, at the same time, causes no disturbances to an electrocardiograph connected to the patient.
Patent AU-2008203803-B2 (AU)
Title: Lubricant compositions with reduced phosphorous content for engines having catalytic converters
Inventor: WADDOUPS MALCOLM
IPC: C10N30/06
Filed: 2008-08-08
Granted: 2012-11-08
Abstract: A lubricant composition is disclosed. The lubricant composition is made up of (a) ashless dispersant; (b) metal-containing detergent; (c) a phosphorus-containing 5 compound; (d) rust inhibitor; and (e) basestock, wherein the lubricant composition has a concentration of phosphorus less than or equal to 0.08 weight %.
Patent AU-2008207484-B2 (AU)
Title: Slot machine with insurance function and control method thereof
Inventor: OKADA KAZUO
IPC: A63F13/10
Filed: 2008-08-22
Granted: 2012-12-20
Abstract: A slot machine of the present invention comprises: a symbol display device capable of variably displaying a plurality of 5 symbols; and a controller, the controller programmed to execute the processing of: (A) executing a normal game in which the plurality of symbols are variably displayed and then stop-displayed by the symbol display device after game media have been BET in number equal to or less than a previously set 10 maximumnumberof BETs, andapayout value is determined according to the stop-displayed symbols or a combination thereof; (B) shifting a mode from a non-insurance mode to an insurance mode on condition that a predetermined number of game media have been inserted; (C) counting the number of normal games played after 15 the mode has been shifted to the insurance mode, in the insurance mode; and (D) paying out a predetermined number of game media and also conducting a free game that is executed even without a game medium BET thereon, when the number of normal games counted in the processing (C) has reached a specific number. Fig. 1 Game execution processing D (insurance mode/at reaching of specific number) Display of insurance mode image (display of the remaining S501 number of games. etc.) Coin is BET? YES, rSubtraction of the number of credits as spin button No been ON? Display of specific effect image Payout of predetermined number S535 (image changing according to number of games) Display of specific effect image in mode making reels viewable S536 To-be-stopped symbol %5632 determination processing a obnto of bonus triggers been YE Reel rotation control processing -S507 established? fContinuous display of S521 specific image display 508 NO Has winning combination been S509 es tabl ished? S523 as combination YSYS 32 of bonus triggers been /E Jackpot payout established? Payout processing processing NO S51 + NO Has winning Display of specific effect image combination been in display window covering mode S540 established? YES :Determination of the S530 number-of-free-games T based on S541 sthe number YES the number-of-MAXBET-games M of payouts equal to or more tha 4 a predetermined Free game execution processing 5542 MA X B E T? (setting insurance mode flag FF) 543 M= M +1 MSS32 Clearing the number of games (setting the number-of- S4 6,all-games C = 0. setting the S4 C=C + 1 S53number-of-MAXBET-games M = 0) (spcif ic number) 53 Display of image notifying S4 Display of specific effect image S3 shifting to non-insurance model SS4 Find'ispay window covering mode S53 IRetr
Patent AU-2008233856-B2 (AU)
Title: Photovoltaic device and process for producing same.
Inventor: YAMAGUCHI KENGO
IPC: H01L31/04
Filed: 2008-02-08
Granted: 2012-11-01
Abstract: Provided are a photoelectric conversion device having high performance at low cost and a method for manufacturing such photoelectric conversion device. A photoelectric conversion device (90) is provided with at least two laminated photoelectric conversion layers, and an intermediate layer (93), which exists between the two photoelectric conversion layers and electrically and optically connects the two photoelectric conversion layers. The photoelectric conversion device is also provided with a plasma resistant protection layer (93A) on a surface of the intermediate layer (93).
Patent AU-2008239018-B2 (AU)
Title: 5-membered heterocyclic derivative and use thereof for medical purposes
Inventor: FUJIKURA HIDEKI
IPC: A61P19/06
Filed: 2008-04-10
Granted: 2013-09-05
Abstract: Disclosed is a compound useful as a prophylactic or therapeutic agent for a disease induced by abnormal plasma uric acid level or the like. Specifically disclosed is a 5-membered heterocyclic derivative represented by the general formula (I), a prodrug or salt thereof, or the like, which has a xanthine oxidase inhibitory activity and is useful as a prophylactic or therapeutic agent for a disease induced by abnormal plasma uric acid level. In the formula (I), T represents a nitro, a cyano or the like; the ring J represents an aryl or a heteroaryl; Q represents a carboxy, a 5-tetrazolyl or the like; Y represents H, OH, NH
Patent AU-2008240155-B2 (AU)
Title: Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics
Inventor: VISHWANATHA JAMBOOR K
IPC: B82B1/00
Filed: 2008-04-11
Granted: 2012-09-20
Abstract: The present invention includes compositions and methods of making an activated polymeric nanoparticle for targeted drug delivery that includes a biocompatible polymer and an amphiphilic stabilizing agent non-covalently associated with a spacer compound that includes at least one electrophile that selectively reacts with any nucleophilic on a targeting agent and places the targeting agent on the exterior surface of a biodegradable nanoshell, wherein an active agent is loaded with the nanoshell.
Patent AU-2008246440-B2 (AU)
Title: A sheet system
Inventor: BARRY KIRSTY
IPC: A47G9/04
Filed: 2008-05-05
Granted: 2013-08-29
Abstract: There is provided a sheet system for securing a child in a preferred position on a sleep surface and covering the child, the sheet system including: a base sheet; a band for securing a child in a preferred position; a first attachment means for attaching the band to the base sheet; a top sheet for covering the secured child, and a second attachment means for attaching the top sheet to the base sheet and a stabilising means for stabilising the base sheet on a sleep surface.
Patent AU-2008248598-B2 (AU)
Title: Organic compounds
Inventor: INES RODRIGUEZ PEREZ MARIA
IPC: C07D401/14
Filed: 2008-05-05
Granted: 2011-11-17
Abstract: A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M, M, L, L, W, W, X, X, Y, Y, A, R and R are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.
Patent AU-2008296141-B2 (AU)
Title: System and method for generating a drive signal
Inventor: BEAVIS RUSSELL HERBERT
IPC: B67D7/08
Filed: 2008-09-05
Granted: 2013-10-17
Abstract: A method and computer program product for defining a PWM drive signal having a defined voltage potential. The PWM drive signal has a plurality of "on" portions and a plurality of "off portions that define a first duty cycle for regulating, at least in part, a flow rate of a pump assembly. At least a portion of the "on" portions of the PWM drive signal are pulse width modulated to define a second duty cycle for the at least a portion of the "on" portions of the PWM drive signal. The second duty cycle regulates, at least in part, the percentage of the defined voltage potential applied to the pump assembly.
Patent AU-2008333034-B2 (AU)
Title: Improved junction device for conveyor belts
Inventor: JAKOB HORST
IPC: F16G3/04
Filed: 2008-09-19
Granted: 2013-04-18
Abstract: The proposed device comprises knuckles (CH) alternately connected to upper fastening plates (PS) and to lower fastening plates (PI). These plates comprise fastening claws (7a, 7b) of which some (7a) are arranged on the front and/or rear edges of the plates (PS, PI) and others (7b) inside the surface of the plates. Stops (9) are provided for blocking the knuckles along the edge of the end of a conveyor belt. Another series of similar knuckles (CH) are placed against the other end of the conveyor belt. The two series of knuckles (CH) and plates are braced against the upper and lower sides of the respective conveyor belt ends, the claws (7a, 7b) fastening them to these ends. A connecting rod is then fitted into the knuckles (CH) of the two pre-interleaved series, bringing together the conveyor belt ends in the process.
Patent AU-2008342628-B2 (AU)
Title: Fluoride processing method
Inventor: JACKSON ALEXANDER
IPC: C01B9/00
Filed: 2008-12-22
Granted: 2014-05-01
Abstract: The invention relates to methods for processing [
Patent AU-2009200732-B2 (AU)
Title: Single port device with multi-lumen cap
Inventor: RICHARD PAUL D
IPC: A61B17/94
Filed: 2009-02-24
Granted: 2014-04-03
Abstract: SINGLE PORT DEVICE WITH MULTI-LUMEN CAP Abstract A surgical access apparatus (300) includes an access member (310a) defining a longitudinal axis and having a longitudinal passageway (312b) for reception and passage of a surgical object and an access housing (305) mountable to the access member. The access housing (305) includes a diaphragm (330) mounted thereto. The diaphragm (330) is adapted for rotational movement about the longitudinal axis relative to the access housing (305). The diaphragm (330) defines at least one internal pocket (332a) and has a seal assembly disposed within the internal pocket. The seal assembly has an interface 10 seal member adapted for establishing a fluid tight seal about the surgical object. The seal assembly is adapted for selective movement within the pocket (332a) about multiple axes in response to manipulation of the surgical object.
Patent AU-2009212135-B2 (AU)
Title: Compounds that enhance Atoh-1 expression
Inventor: CUNY GREGORY D
IPC: A61K31/343
Filed: 2009-02-09
Granted: 2014-08-21
Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.